Altered cerebrovenous drainage in patients with migraine as assessed by phase-contrast magnetic resonance imaging

Investigative Radiology

Volumn 46, Issue 7, 2011, Pages 434-440

  Koerte, Inga K ^a   Schankin, Christoph J ^b   Immler, Stefanie ^a   Lee, Sang ^c   Laubender, Ruediger P ^b   Grosse, Christina ^a   Eftimov, Lara ^a   Milde Busch, Astrid ^b   Reiser, Maximilian ^a   Straube, Andreas ^b   Heinen, Florian ^a   Alperin, Noam ^c   Ertl Wagner, Birgit ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Migraine; Phase contrast imaging; Secondary venous channels; Total cerebral blood flow; Venous outflow

Indexed keywords

AMITRIPTYLINE; LAMOTRIGINE; METOPROLOL; NEBIVOLOL; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN VEIN; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NECK; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHASE CONTRAST MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PRIORITY JOURNAL; TREATMENT DURATION; VEIN BLOOD FLOW; VENOUS CIRCULATION;

EID: 79960015063     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318210ecf5     Document Type: Article

References (32)

1. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7:354-361. (Pubitemid 351380536)
2. Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126(pt 1):241-247. (Pubitemid 36068573)
3. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007;13:39-44. (Pubitemid 46027728)
4. Alperin N, Lee SH, Mazda M, et al. Evidence for the importance of extracranial venous flow in patients with idiopathic intracranial hypertension (IIH). Acta Neurochir Suppl. 2005;95:129-132.
5. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:392-399.
6. Zamboni P, Menegatti E, Bartolomei I, et al. Intracranial venous haemodynamics in multiple sclerosis. Curr Neurovasc Res. 2007;4:252-258. (Pubitemid 350171825)
7. Sundstrom P, Wahlin A, Ambarki K, et al. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol. 2010;68:255-259.
8. Worthington V, Killestein J, Eikelenboom MJ, et al. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology. 2010;75:1617-1622.
9. Wattjes MP, van Oosten BW, de Graaf WL, et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry. In press.
10. San Millan Ruiz D, Gailloud P, Rufenacht DA, et al. The craniocervical venous system in relation to cerebral venous drainage. Am J Neuroradiol. 2002;23:1500-1508. (Pubitemid 35154990)
11. Alperin N, Lee SH, Sivaramakrishnan A, et al. Quantifying the effect of posture on intracranial physiology in humans by MRI flow studies. J Magn Reson Imaging. 2005;22:591-596. (Pubitemid 41572710)
12. Doepp F, Schreiber SJ, von Munster T, et al. How does the blood leave the brain? A systematic ultrasound analysis of cerebral venous drainage patterns. Neuroradiology. 2004;46:565-570. (Pubitemid 39144791)
13. Stoquart-Elsankari S, Lehmann P, Villette A, et al. A phase-contrast MRI study of physiologic cerebral venous flow. J Cereb Blood Flow Metab. 2009;29:1208-1215.
14. Batson OV. The vertebral vein system. Caldwell lecture, 1956. Am J Roentgenol Radium Ther Nucl Med. 1957;78:195-212.
15. Headache Classification S. The international classification of headache disorders. Cephalalgia. 2004;24(suppl 1):1-160.
16. Tain RW, Ertl-Wagner B, Alperin N. Influence of the compliance of the neck arteries and veins on the measurement of intracranial volume change by phase-contrast MRI. J Magn Reson Imaging. 2009;30:878-883.
17. Alperin N, Lee SH. PUBS: pulsatility-based segmentation of lumens conducting non-steady flow. Magn Reson Med. 2003;49:934-944. (Pubitemid 36523481)
18. Wagshul ME, Chen JJ, Egnor MR, et al. Amplitude and phase of cerebrospinal fluid pulsations: experimental studies and review of the literature. J Neurosurg. 2006;104:810-819.
19. Gisolf J, van Lieshout JJ, van Heusden K, et al. Human cerebral venous outflow pathway depends on posture and central venous pressure. J Physiol. 2004;560(pt 1):317-327. (Pubitemid 39406035)
20. McNaughton F, Feindel W. Innervation of intracranial structures: a reappraisal. In: Rose FC, ed. Physiological Aspects of Clinical Neurology. Oxford, England: Blackwell Scientific Publications; 1977.
21. Goadsby PJ, Duckworth JW. Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol. 1987;253(2 pt 2):R270-R274.
22. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193-196. (Pubitemid 18081459)
23. Goadsby PJ, MacDonald GJ. Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP). Brain Res. 1985;329:285-288. (Pubitemid 15141301)
24. Gallai V, Sarchielli P, Floridi A, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 1995;15:384-390.
25. Van Den Brink AM, Duncker DJ, Saxena PR. Migraine headache is not associated with cerebral or meningeal vasodilatation-a 3T magnetic resonance angiography study. Brain. 2009;132(pt 6):e112; author reply e113.
26. Schoonman GG, van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation-a 3T magnetic resonance angiography study. Brain. 2008;131(pt 8):2192-2200.
27. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98:4687-4692. (Pubitemid 32295037)
28. Choudhuri R, Cui L, Yong C, et al. Cortical spreading depression and gene regulation: relevance to migraine. Ann Neurol. 2002;51:499-506. (Pubitemid 34260780)
29. Vause CV, Durham PL. Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis. Neurosci Lett. 12;473:163-167.
30. Mason RP, Giles TD, Sowers JR. Evolving mechanisms of action of beta blockers: focus on nebivolol. J Cardiovasc Pharmacol. 2009;54:123-128.
31. Kalkan S, Hocaoglu N, Akgun A, et al. Effects of adenosine receptor antagonists on amitriptyline-induced vasodilation in rat isolated aorta. Clin Toxicol (Phila). 2007;45:600-604.
32. Tronvik E, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003;289:65-69. (Pubitemid 36026279)